Genzyme’s MS drug approved in Mexico, but still no word on U.S. appeal
February 06, 2014 at 14:33 PM EST
While there is still no news from drug giant Genzyme Corp. about its appeal of the rejection by U.S. regulators of its multiple sclerosis drug, Lemtrada, the company can now add one more country to the list of those that have approved it...